64x Bio

A comprehensive platform and product suite for advanced therapeutics.

Health and bio Education Manufacturing and industrialY Combinator

Latest funding

$55M Series A · January 19, 2022

Led by Lifeforce Capital · Source: fundraisingfox.com

All 2 rounds ↓

Website: 64xbio.com.

X: @64xbio · 1,374 followers.

LinkedIn: linkedin.com.

Categories: Health and bio Education Manufacturing and industrial.

Sectors: Healthcare, Industrial Bio, Gene Therapy, Machine Learning.

Stage: Series A.

Based in: San Francisco, United States.

Founded: 2017.

Last round: Jan 19, 2022 · 1,758 days ago.

Team: 25 people on the team page.

On Recent Funding since: Sep 28, 2026.

Signals

X account@64xbio · created Jul 27, 2018 (8 years old) · 1,374 followers

Website registeredJun 17, 2020 (6 years old)

TIMELINE · MONEY RAISED

64x Bio | 1272 days from X account to first raise on record

@64xbio·Raised $55M in 1 sourced round·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

January 19, 2022
Series A · $55M
LLifeforce Capital (lead), CChristopher Gibson, FFifty Years, FFirst Round Capital, FFuture Ventures, LLiquid 2 Ventures, MMichael Chambers, NNorthpond Ventures, RRefactor, SSV Angel
Source: fundraisingfox.com
June 17, 2020
Website created
July 27, 2018
X account created
Summer 2018
YY Combinator · batch
Source: ycombinator.com

Founders and team

LR
Lexi Rovner Co-founder & CEO

LinkedIn · source: foundertrace.com
AR
Alexis Rovner Founder

@lexrovner · LinkedIn
DT
David Thompson Founder
F(
Farhad (Seyyedhassan) Paylakhi Co-founder, Vice President R&D

LinkedIn · source: foundertrace.com
GC
George Church Founder
JW
Jeffrey Way Founder

LinkedIn
PS
Pamela Silver Founder

Investors

Companies like 64x Bio

LLuriSeed · Feb 2026
AAnatomySeries A · Dec 2024
GGeneral Analysis$10M Seed · Apr 2026
CCyDeploy$1.1M Pre Seed · Mar 2023

Other companies backed by Lifeforce Capital

EEnveda$311M Series B+ · Sep 2026
AAspen Neuroscience$115M Series B+ · Nov 2025
CCharacter Bio$93M Series B+ · Mar 2025
FFauna BioSeries A · Mar 2025

Lifeforce Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/64x-bio (get a free API key).